Pfizer announced a $10 billion global licensing deal with China's Innovent Biologics on 28 May 2026, covering 12 oncology assets. The deal arrives as U.S. lawmakers debate expanding outbound-investment screening to biotech—a contradiction exposing the gap between national security rhetoric and commercial incentives. No current U.S. rule imposes a blanket…
Daily news from Asia-Pacific straight to you inbox.
Super El Niño and Iran's Hormuz closure converge to threaten Asia's power grids, agriculture, and manufacturing. Ocean temperatures could exceed…
Singapore's tourism sector recorded 16.9 million international visitor arrivals in 2025 and S$32.8 billion in tourism receipts. However, the Singapore…
Economy fares on Europe-East Asia routes have surged 24% on average since…
India is enduring a severe and worsening heatwave season, with New Delhi's…
Thailand's Cabinet approved a THB 176 billion (USD 5.39 billion) relief package,…
HSBC has launched a $4-billion Sustainability and Transition Credit Facility to finance…
As of February 12, 2026, the UK Foreign, Commonwealth & Development Office…
On May 16–17, 2026, Xi Jinping and Vladimir Putin signed two joint…
Canadian passport holders can now enter China visa-free for stays up to…
A threatened 18-day strike by the National Samsung Electronics Union, representing approximately…
The Iran war, starting Feb 28, 2026, has cut 1.6 million tonnes…
Kuala Lumpur-based startup Zetrix AI targets 1 million users for its autonomous…
United Airlines is replacing its Guam-based Boeing 737-800s with new 737 MAX…
Europe has approximately six weeks of jet fuel supply remaining before shortages…
